Inhibition of insulin, glucose-dependant insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) secretion by octreotide has no effect on post-heparin plasma lipoprotein lipase activity

被引:11
作者
Ranganath, LR [1 ]
Beety, JM
Morgan, LM
机构
[1] Epsom Gen Hosp, Dept Chem Pathol, Epsom KT18 7EG, Surrey, England
[2] Univ Surrey, Sch Biol Sci, Guildford GU2 5XH, Surrey, England
关键词
obesity; insulin; GIP; GLP-1; octreotide; heparin; plasma lipoprotein lipase activity;
D O I
10.1055/s-2007-978729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study examines the immediate effect of modulating postprandial insulin and insulinotropic hormone (glucose-dependent insulinotropic polypeptide, GIP; glucagon-like peptide-1, GLP-1) secretion on the activation of lipoprotein lipase (LPL) in six lean and six obese age-matched women. Subjects were given, on two separate occasions, 340 kcal of carbohydrate alone or combined with an IV infusion of octreotide, (100 mu g infusion from 30 min before the meal for 150 min). Post-heparin LPL activity (10,000 U) was measured on each occasion 120 minutes post-carbohydrate. Following oral carbohydrate postprandial plasma insulin levels were significantly higher in obese subjects than in lean (p<0.01), Glucose tolerance was slightly impaired in obese subjects. Insulin, GIP and GLP-1 secretion post-carbohydrate was markedly reduced by octreotide in lean and obese subjects. LPL activity was similar in the two groups after carbohydrate administration and was unaffected by octreotide. Inhibition of postprandial insulin, GIP and GLP-1 secretion acutely did not reduce post-heparin LPL activity either in lean or obese subjects.
引用
收藏
页码:262 / 266
页数:5
相关论文
共 17 条
  • [1] OCTREOTIDE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN CONDITIONS ASSOCIATED WITH EXCESSIVE PEPTIDE SECRETION
    BATTERSHILL, PE
    CLISSOLD, SP
    [J]. DRUGS, 1989, 38 (05) : 658 - 702
  • [2] WEIGHT-REDUCTION INCREASES ADIPOSE BUT DECREASES CARDIAC LPL IN REDUCED-OBESE ZUCKER RATS
    BESSESEN, DH
    ROBERTSON, AD
    ECKEL, RH
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (02): : E246 - E251
  • [3] ECKEL RH, 1989, NEW ENGL J MED, V320, P1060
  • [4] ECKEL RH, 1978, DIABETES, V28, P1141
  • [5] MECHANISMS OF INCREASED LIPOPROTEIN-LIPASE IN FAT-CELLS OF OBESE ZUCKER RATS
    FRIED, SK
    TURKENKOPF, IJ
    GOLDBERG, IJ
    DOOLITTLE, MH
    KIRCHGESSNER, TG
    SCHOTZ, MC
    JOHNSON, PR
    GREENWOOD, MRC
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (05): : E653 - E660
  • [6] ENDOCRINE FUNCTION IN HUMAN OBESITY
    GLASS, AR
    BURMAN, KD
    DAHMS, WT
    BOEHM, TM
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1981, 30 (01): : 89 - 104
  • [7] HAMPTON SM, 1993, DIABETES METAB, V19, P582
  • [8] INOUE S, 1990, PROGR OBESITY RES, P95
  • [9] KARPE F, 1992, J LIPID RES, V33, P975
  • [10] KNAPPER JME, 1995, J NUTR, V125, P183